Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of osteoarthritis with allogeneic mesenchymal stromal cells (MSV)
2011-005321-51Phase 2Completed
- Sponsor
- Parque Científico de la Universidad de Valladolid
- Start
- Nov 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of allogeneic bone marrow-derived mesenchymal stromal cells in knee osteoarthritis (OA), sponsored by Parque Científico de la Universidad de Valladolid. Primary endpoint: Clinical efficacy. Started Nov 2011; status: completed.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2011-005321-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005321-51.